IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo.
Myeloid cells, such as macrophages and microglia, play a crucial role in neuroinflammation and have been recently identified as a novel therapeutic target, especially for chronic forms. The general aim would be to change the phenotype of myeloid cells from pro- to anti-inflammatory, favoring their tissue-trophic and regenerative functions. Myeloid cells, however, display a number of functional phenotypes, not immediately identifiable as pro- or anti-inflammatory, and associated to ambiguous markers.



We employed in vitro assays to study macrophage polarization/differentiation in the presence of classical polarizing stimuli such as IFNγ (pro-inflammatory) and IL4 (anti-inflammatory). We induced neuroinflammation in mice by immunization with a myelin antigen and treated diseased mice with intracisternal delivery of an IL4-expressing lentiviral vector. We analyzed clinical, pathological, and immunological outcomes with a focus on myeloid cells.



We found that IL6, usually considered a pro-inflammatory cytokine, was released in vitro by macrophages treated with the anti-inflammatory cytokine IL4. We show the existence of macrophages expressing IL6 along with classical anti-inflammatory markers such as CD206 and demonstrate that these cells are immunosuppressive in vitro. In neuroinflamed mice, we show that IL4 delivery in the central nervous system (CNS) is associated with clinical and pathological protection from disease, associated with increased IL6 expression in infiltrating macrophages.



IL6 is known to mediate both pro- and anti-inflammatory effects, having two distinct ways to induce cell-signaling: either through the membrane bound receptor (anti-inflammatory) or through trans-signaling (pro-inflammatory). We show here that IL6-expressing macrophages are associated to protection from neuroinflammation, suggesting that IL6 anti-inflammatory properties prevail in the CNS, and calling for a general reconsideration of IL6 in macrophage polarization.
Clinical Neuroimmunology Unit, Institute of Experimental Neurology-INSpe, Division of Neuroscience, San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
Giacomo
G
Casella
Clinical Neuroimmunology Unit, Institute of Experimental Neurology-INSpe, Division of Neuroscience, San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
Livia
L
Garzetti
Clinical Neuroimmunology Unit, Institute of Experimental Neurology-INSpe, Division of Neuroscience, San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
Alberto T
AT
Gatta
Clinical Neuroimmunology Unit, Institute of Experimental Neurology-INSpe, Division of Neuroscience, San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
Annamaria
A
Finardi
Clinical Neuroimmunology Unit, Institute of Experimental Neurology-INSpe, Division of Neuroscience, San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
Chiara
C
Maiorino
Neuroimmunology Unit, Institute of Experimental Neurology-INSpe, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
Francesca
F
Ruffini
Neuroimmunology Unit, Institute of Experimental Neurology-INSpe, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
Gianvito
G
Martino
Neuroimmunology Unit, Institute of Experimental Neurology-INSpe, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
Luca
L
Muzio
Clinical Neuroimmunology Unit, Institute of Experimental Neurology-INSpe, Division of Neuroscience, San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy. furlan.roberto@hsr.it.
Roberto
R
Furlan
D000818:Animals; D002478:Cells, Cultured; D018920:Coculture Techniques; D004305:Dose-Response Relationship, Drug; D005260:Female; D007249:Inflammation / Q000276:immunology / Q000378:metabolism / Q000517:prevention & control; D018836:Inflammation Mediators / Q000037:antagonists & inhibitors / Q000276:immunology / Q000378:metabolism*; D015847:Interleukin-4 / Q000276:immunology / Q000494:pharmacology*; D015850:Interleukin-6 / Q000096:biosynthesis* / Q000276:immunology; D008264:Macrophages / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL
D018836:Inflammation Mediators; D015850:Interleukin-6; C577686:interleukin-6, mouse; D015847:Interleukin-4
Autoimmunity; EAE; IL4; IL6; M2 macrophages